Comparison
3 Methylglutaconic Aciduria C3696376 vs 3 5 Toe Syndactyly C4023723
Clinical comparison between 3 Methylglutaconic Aciduria and 3 5 Toe Syndactyly for differential diagnosis and treatment planning.
3 Methylglutaconic Aciduria C3696376
A metabolic disorder causing abnormal acid buildup affecting multiple body systems including the brain. Severity varies widely among affected individuals. Care focuses on symptom management and metabolic support.
3 5 Toe Syndactyly C4023723
A condition where the 3rd, 4th, and 5th toes are fused together, usually present from birth. It may affect walking or balance. Treatment involves surgery to separate the toes if it causes functional problems.
6 comparison axes
Onset
3 Methylglutaconic Aciduria C3696376
0-10
3 5 Toe Syndactyly C4023723
0-0
Onset patterns differ
Severity
3 Methylglutaconic Aciduria C3696376
severe
3 5 Toe Syndactyly C4023723
mild
Different severity levels
Chronic
3 Methylglutaconic Aciduria C3696376
Chronic
3 5 Toe Syndactyly C4023723
Chronic
Differing course
Communicable
3 Methylglutaconic Aciduria C3696376
No
3 5 Toe Syndactyly C4023723
No
Different transmission
Body System
3 Methylglutaconic Aciduria C3696376
metabolic
3 5 Toe Syndactyly C4023723
musculoskeletal
Same/different system
Category
3 Methylglutaconic Aciduria C3696376
metabolic
3 5 Toe Syndactyly C4023723
genetic
Different category
Bottom line
3-methylglutaconic-aciduria-C3696376 and 3-5-toe-syndactyly-C4023723 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Methylglutaconic Aciduria C3696376 | 3 5 Toe Syndactyly C4023723 | Discriminating power |
|---|---|---|---|
| Neurologic or developmental change | May include developmental delay, movement problems, or other neurologic features; severity varies. | No neurologic disease is implied by toe fusion alone. | High |
| Foot appearance | Toe fusion is not a defining feature of the metabolic condition. | Third, fourth, and fifth toes are fused from birth. | High |
| Systemic illness | May involve metabolic decompensation and multiple body systems. | Usually limited to the foot; walking or balance may be affected. | Moderate |
When to favor each condition
Choose 3 Methylglutaconic Aciduria C3696376 when
Unexplained neurologic or developmental concerns with suspected organic aciduria
The metabolic diagnosis is supported by biochemical and clinical evaluation, not appearance alone.
High
Episodes suggesting metabolic stress
Care centers on symptom management and metabolic support when a clinician confirms the disorder.
Moderate
Need to distinguish a laboratory abnormality from a named subtype
3-methylglutaconic aciduria is a finding or group of disorders; subtype requires specialist interpretation.
High
Choose 3 5 Toe Syndactyly C4023723 when
Congenital fusion limited to toes 3-5
The finding is structural and usually recognized at birth.
High
Functional walking or footwear difficulty without systemic disease
Surgical separation may be considered if function is impaired.
Moderate
Isolated musculoskeletal concern
Toe syndactyly does not by itself indicate a metabolic disorder.
High
How key tests differ
| Test | 3 Methylglutaconic Aciduria C3696376 | 3 5 Toe Syndactyly C4023723 | Interpretation |
|---|---|---|---|
| Urine organic acid analysis | May show elevated 3-methylglutaconic acid; exact cutoffs are not established here. | Not indicated by isolated toe syndactyly. | An abnormal result supports further metabolic evaluation but is not itself a complete diagnosis. |
| Physical and radiographic foot examination | No characteristic toe-fusion pattern is established. | Demonstrates fusion of the third through fifth toes and related anatomy. | Imaging clarifies structure and surgical planning when function is affected. |
| Genetic or metabolic specialist testing | May be used to investigate cause and subtype when clinically indicated. | May be considered if additional congenital anomalies suggest a broader syndrome. | Testing choice depends on the full phenotype; results require clinician interpretation. |
Prognosis comparison
3 Methylglutaconic Aciduria C3696376
- Outcome
- Highly variable; some people have significant multisystem disease, while severity cannot be assumed from the name.
- Factors
- Subtype, neurologic involvement, metabolic stability, and supportive care.
3 5 Toe Syndactyly C4023723
- Outcome
- Often mild; function may improve with observation, orthotic support, or surgery when needed.
- Factors
- Extent of fusion, walking or balance effects, and associated anomalies.
Time frame: Aciduria is generally chronic; syndactyly is congenital and persistent unless surgically altered.
Prognosis should be individualized; no mortality or universal outcome is established here.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic impairment | Possible and variable; not predictable from the label alone. Not expected from isolated toe syndactyly. Any neurologic concern needs individual assessment. |
| Mobility limitation | May occur from neurologic or systemic disease. May occur from toe fusion, balance difficulty, or footwear problems. Causes and management differ substantially. |
| Metabolic decompensation | A recognized concern in some affected people. Not a feature of toe syndactyly. Emergency thresholds and treatment are individualized and not specified here. |
Patient education highlights
- HighDifferent conditions
Aciduria concerns metabolism; toe syndactyly concerns foot structure. One does not explain the other.
- HighWhen to seek care
Seek urgent care for concerning metabolic or neurologic symptoms as directed by a clinician.
- MediumFunction and follow-up
Foot surgery is considered for functional problems; metabolic care focuses on monitoring and support.